ClinicalTrials.Veeva

Menu

Effects of an Integrated Multimodal Lifestyle Intervention for Management of Violence in Schizophrenia

I

I-Shou University

Status

Completed

Conditions

Schizophrenia

Treatments

Other: an integrated multimodal lifestyle intervention (MLifeI)

Study type

Interventional

Funder types

Other

Identifiers

NCT05229484
IShouU-cholesterol I

Details and patient eligibility

About

Total cholesterol levels and other lipids are associated with violence in psychiatric patients. There is a paucity of studies on preventive interventions. In this study, an integrated multimodal lifestyle intervention (MLifeI) for management of repetitive violence in schizophrenia is proposed. A controlled clinical trial was carried out to evaluate the effects of MLifeI on management of repetitive violence through regulation of serum lipids, TC in particular, to the recommended levels in schizophrenia. The investigators examined whether the MLifeI could: 1. regulate or balance lipid profiles; 2. reduce violence risk; 3. improve impulsivity; and 4. improve general cognitive functioning.

Full description

Total cholesterol levels and other lipids are associated with violence in psychiatric patients. There is a paucity of studies on preventive interventions. In this study, an integrated multimodal lifestyle intervention (MLifeI) for management of repetitive violence in schizophrenia is proposed. A controlled clinical trial was carried out to evaluate the effects of MLifeI on management of repetitive violence through regulation of serum lipids, TC in particular, to the recommended levels in schizophrenia. The investigators examined whether the MLifeI could: 1. regulate or balance lipid profiles; 2. reduce violence risk; 3. improve impulsivity; and 4. improve general cognitive functioning. The multimodal lifestyle intervention included psychoeducation, lifestyle modification and health promotion and exercise. Outcome measures comprised lipid profiles, body mass index and violence-related parameters.

Enrollment

62 patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of schizophrenia for more than 2 years
  • Psychiatrically hospitalized
  • Repetitive violence within one year
  • Ambulatory
  • Having basic literacy
  • More than 20 years old
  • Less than 65 years old

Exclusion criteria

  • Clinical psychiatric diagnosis other than schizophrenia
  • Physical co-morbidity or life-threatening illnesses that may impact on lipid homeostasis
  • dietary restrictions for physical condition
  • pregnancy
  • reported disabilities
  • impairments or health illness/problems that significantly limited their ability to perform the intervention such as severe arthritis, uncorrected visual or hearing impairments, developmental disability, or signs of intellectual disability.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

62 participants in 2 patient groups

Intervention Group: an integrated multimodal lifestyle intervention (MLifeI)
Experimental group
Description:
The MLifeI program focused on the roles of health responsibility, review of lipid profile, complications of imbalanced lipid profile, lipid management and nutritional education.
Treatment:
Other: an integrated multimodal lifestyle intervention (MLifeI)
Control group
No Intervention group
Description:
The control group is the Treatment as Usual (TAU).

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems